Tina Ntoukas-Dietrich

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Adjuvant Crosslinking to Improve Graft Survival after High-Risk Keratoplasty - A Case Series from the CrossCornealVision Study

Adjuvant Crosslinking to Improve Graft Survival after High-Risk Keratoplasty - A Case Series from the CrossCornealVision Study

Journal: Klinische Monatsblatter fur Augenheilkunde

Published: May 07, 2026

Descemet membrane endothelial keratoplasty in patients after radiation therapy for uveal melanoma.

Descemet membrane endothelial keratoplasty in patients after radiation therapy for uveal melanoma.

Journal: BMC ophthalmology

Published: December 10, 2025

Bilateral visual impairment caused by Toxoplasma gondii encephalitis and ocular GVHD in a patient after allo-HSCT.

Bilateral visual impairment caused by Toxoplasma gondii encephalitis and ocular GVHD in a patient after allo-HSCT.

Journal: Journal of ophthalmic inflammation and infection

Published: October 26, 2025

Prospective evaluation of patient reported outcome measures (PROMs) and correlation with clinical parameters of chronic ocular graft-versus-host disease (GVHD).

Prospective evaluation of patient reported outcome measures (PROMs) and correlation with clinical parameters of chronic ocular graft-versus-host disease (GVHD).

Journal: The ocular surface

Published: August 06, 2025

Comorbidities, clinical outcome and rate of herpes simplex positive PCR in patients with keratitis, corneal erosions and ulcers.

Comorbidities, clinical outcome and rate of herpes simplex positive PCR in patients with keratitis, corneal erosions and ulcers.

Journal: Journal of ophthalmic inflammation and infection

Published: April 06, 2025

Nerve Growth Factor Modulates Regulatory Cell Volume Behavior via Stimulating TRPV1, TRPM8 Channels and Inducing Ca2+ Signaling in Human Conjunctival Epithelial Cells.

Nerve Growth Factor Modulates Regulatory Cell Volume Behavior via Stimulating TRPV1, TRPM8 Channels and Inducing Ca2+ Signaling in Human Conjunctival Epithelial Cells.

Journal: Cells

Published: April 04, 2025

Ocular graft versus host disease

Ocular graft versus host disease

Journal: Die Ophthalmologie

Published: February 18, 2025

Complement Component C5a and Fungal Pathogen Induce Diverse Responses through Crosstalk between Transient Receptor Potential Channel (TRPs) Subtypes in Human Conjunctival Epithelial Cells.

Complement Component C5a and Fungal Pathogen Induce Diverse Responses through Crosstalk between Transient Receptor Potential Channel (TRPs) Subtypes in Human Conjunctival Epithelial Cells.

Journal: Cells

Published: June 28, 2024

Frequency of Topical Immunomodulatory and Immunosuppressive Therapies for Ocular Chronic Graft-versus-Host Disease.

Frequency of Topical Immunomodulatory and Immunosuppressive Therapies for Ocular Chronic Graft-versus-Host Disease.

Journal: Journal of clinical medicine

Published: June 24, 2024

Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal Transplantation.

Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal Transplantation.

Journal: Journal of clinical medicine

Published: May 30, 2024

Ocular Involvement in Graft-versus-Host Disease.

Ocular Involvement in Graft-versus-Host Disease.

Journal: Klinische Monatsblatter fur Augenheilkunde

Published: January 23, 2024

UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial.

UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial.

Journal: Trials

Published: November 20, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026